Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer

<b>Objective: </b> Cancer-associated inflammation and coagulation cascades play vital roles in cancer progression and survival. In this study, we investigated the significance of the combination of preoperative fibrinogen and the neutrophil-to-lymphocyte ratio (NLR) in predicting the sur...

Full description

Bibliographic Details
Main Authors: Wuhao Huang, Shengguang Wang, Hua Zhang, Bin Zhang, Changli Wang
Format: Article
Language:English
Published: China Anti-Cancer Association 2018-03-01
Series:Cancer Biology & Medicine
Subjects:
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1094
_version_ 1819092280815910912
author Wuhao Huang
Shengguang Wang
Hua Zhang
Bin Zhang
Changli Wang
author_facet Wuhao Huang
Shengguang Wang
Hua Zhang
Bin Zhang
Changli Wang
author_sort Wuhao Huang
collection DOAJ
description <b>Objective: </b> Cancer-associated inflammation and coagulation cascades play vital roles in cancer progression and survival. In this study, we investigated the significance of the combination of preoperative fibrinogen and the neutrophil-to-lymphocyte ratio (NLR) in predicting the survival of patients with non-small cell lung cancer (NSCLC). <b>Methods: </b> We retrospectively enrolled 589 patients with NSCLC who underwent surgery. The univariate and multivariate Cox survival analyses were used to evaluate the prognostic indicators, including the combination of fibrinogen and NLR (F-NLR). The cut-off values for fibrinogen, NLR, and clinical laboratory variables were defined by the receiver operating characteristic (ROC) curve analysis. According to the ROC curve, the recommended cut-off values for fibrinogen and the NLR were 3.48 g/L and 2.30, respectively. Patients with both a high NLR (≥ 2.30) and hyperfibrinogenemia (≥ 3.48 g/L) were given a score of 2, whereas those with one or neither were scored as 1 or 0, respectively. <b>Results: </b> Our results showed that F-NLR was an independent prognostic indicator for disease-free survival (DFS) [hazard ratio (HR), 1.466; 95% confidence interval (CI), 1.243–1.730; <i>P</i> &lt; 0.001] and overall survival (OS) (HR, 1.512; 95% CI, 1.283–1.783; <i>P</i> &lt; 0.001). The five-year OS rates were 66.1%, 53.5%, and 33.3% for the F-NLR = 0, F-NLR = 1, and F-NLR = 2, respectively (<i>P</i> &lt; 0.001). Correspondingly, their five-year DFS rates were 62.2%, 50.3%, and 30.4%, respectively (<i>P</i> &lt; 0.001). In the subgroup analyses of the pathological stages, the F-NLR level was significantly correlated with DFS and OS in stage I and IIIA cancers. <b>Conclusions: </b> Preoperative F-NLR score can be used as a valuable prognostic marker for patients with resectable early-stage NSCLC.
first_indexed 2024-12-21T22:53:07Z
format Article
id doaj.art-01daaf3a9d8d4726a8d26f751099e143
institution Directory Open Access Journal
issn 2095-3941
2095-3941
language English
last_indexed 2024-12-21T22:53:07Z
publishDate 2018-03-01
publisher China Anti-Cancer Association
record_format Article
series Cancer Biology & Medicine
spelling doaj.art-01daaf3a9d8d4726a8d26f751099e1432022-12-21T18:47:30ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412095-39412018-03-01151889610.20892/j.issn.2095-3941.2017.01242017000124Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancerWuhao HuangShengguang WangHua Zhang0Bin Zhang1Changli Wang2Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Ministry of Education, Tianjin’s Clinical Research Center for Cancer; Tianjin Lung Cancer Center, Tianjin 300060, ChinaDepartment of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Ministry of Education, Tianjin’s Clinical Research Center for Cancer; Tianjin Lung Cancer Center, Tianjin 300060, ChinaDepartment of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Ministry of Education, Tianjin’s Clinical Research Center for Cancer; Tianjin Lung Cancer Center, Tianjin 300060, China<b>Objective: </b> Cancer-associated inflammation and coagulation cascades play vital roles in cancer progression and survival. In this study, we investigated the significance of the combination of preoperative fibrinogen and the neutrophil-to-lymphocyte ratio (NLR) in predicting the survival of patients with non-small cell lung cancer (NSCLC). <b>Methods: </b> We retrospectively enrolled 589 patients with NSCLC who underwent surgery. The univariate and multivariate Cox survival analyses were used to evaluate the prognostic indicators, including the combination of fibrinogen and NLR (F-NLR). The cut-off values for fibrinogen, NLR, and clinical laboratory variables were defined by the receiver operating characteristic (ROC) curve analysis. According to the ROC curve, the recommended cut-off values for fibrinogen and the NLR were 3.48 g/L and 2.30, respectively. Patients with both a high NLR (≥ 2.30) and hyperfibrinogenemia (≥ 3.48 g/L) were given a score of 2, whereas those with one or neither were scored as 1 or 0, respectively. <b>Results: </b> Our results showed that F-NLR was an independent prognostic indicator for disease-free survival (DFS) [hazard ratio (HR), 1.466; 95% confidence interval (CI), 1.243–1.730; <i>P</i> &lt; 0.001] and overall survival (OS) (HR, 1.512; 95% CI, 1.283–1.783; <i>P</i> &lt; 0.001). The five-year OS rates were 66.1%, 53.5%, and 33.3% for the F-NLR = 0, F-NLR = 1, and F-NLR = 2, respectively (<i>P</i> &lt; 0.001). Correspondingly, their five-year DFS rates were 62.2%, 50.3%, and 30.4%, respectively (<i>P</i> &lt; 0.001). In the subgroup analyses of the pathological stages, the F-NLR level was significantly correlated with DFS and OS in stage I and IIIA cancers. <b>Conclusions: </b> Preoperative F-NLR score can be used as a valuable prognostic marker for patients with resectable early-stage NSCLC.http://www.cancerbiomed.org/index.php/cocr/article/view/1094Non-small cell lung cancerneutrophil-to-lymphocyte ratiofibrinogen; prognosis
spellingShingle Wuhao Huang
Shengguang Wang
Hua Zhang
Bin Zhang
Changli Wang
Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer
Cancer Biology & Medicine
Non-small cell lung cancer
neutrophil-to-lymphocyte ratio
fibrinogen; prognosis
title Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer
title_full Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer
title_fullStr Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer
title_full_unstemmed Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer
title_short Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer
title_sort prognostic significance of combined fibrinogen concentration and neutrophil to lymphocyte ratio in patients with resectable non small cell lung cancer
topic Non-small cell lung cancer
neutrophil-to-lymphocyte ratio
fibrinogen; prognosis
url http://www.cancerbiomed.org/index.php/cocr/article/view/1094
work_keys_str_mv AT wuhaohuang prognosticsignificanceofcombinedfibrinogenconcentrationandneutrophiltolymphocyteratioinpatientswithresectablenonsmallcelllungcancer
AT shengguangwang prognosticsignificanceofcombinedfibrinogenconcentrationandneutrophiltolymphocyteratioinpatientswithresectablenonsmallcelllungcancer
AT huazhang prognosticsignificanceofcombinedfibrinogenconcentrationandneutrophiltolymphocyteratioinpatientswithresectablenonsmallcelllungcancer
AT binzhang prognosticsignificanceofcombinedfibrinogenconcentrationandneutrophiltolymphocyteratioinpatientswithresectablenonsmallcelllungcancer
AT changliwang prognosticsignificanceofcombinedfibrinogenconcentrationandneutrophiltolymphocyteratioinpatientswithresectablenonsmallcelllungcancer